Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Soranzo

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Minerva Medica|June 30, 1983
[Fight against infective diseases. Consequences of the persistence in time of hepatitis B virus in the human body]M L Soranzo
Minerva Medica|February 3, 1974
[Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action]M L Soranzo
Minerva Medica|November 1, 1993
[Immunoprophylaxis in the patient at risk. Problems, available vaccines, responses]M L Soranzo, M Busso
Minerva Medica|November 17, 1972
[Clinical experiments with a new derivative of 6-aminopenicillanic acid: hetacillin potassium]M L Soranzo, G Bosio
Minerva Medica|February 18, 1983
[Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects]F Di Nola, M L Soranzo
Minerva Medica|January 20, 1973
[Sedative therapy in tetanus]F Di Nola, M L Soranzo
Panminerva Medica|April 1, 1972
Virus infections and endocrine diseasesF Di Nola, M L Soranzo
Giornale Di Malattie Infettive E Parassitarie|October 1, 1970
[Incidence of encephalitis caused by parotitis]M L Soranzo, G C Paggi
Minerva Medica|March 17, 1973
[On the chemoantibiotic therapy of brucellosis]F Di Nola, M L Soranzo
Minerva Medica|April 14, 1983
[Pneumococcal infections]F Di Nola, M L Soranzo
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Minerva Medica|June 30, 1983
[Fight against infective diseases. Consequences of the persistence in time of hepatitis B virus in the human body]M L Soranzo
Minerva Medica|February 3, 1974
[Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action]M L Soranzo
Minerva Medica|November 1, 1993
[Immunoprophylaxis in the patient at risk. Problems, available vaccines, responses]M L Soranzo, M Busso
Minerva Medica|November 17, 1972
[Clinical experiments with a new derivative of 6-aminopenicillanic acid: hetacillin potassium]M L Soranzo, G Bosio
Minerva Medica|February 18, 1983
[Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects]F Di Nola, M L Soranzo
Minerva Medica|January 20, 1973
[Sedative therapy in tetanus]F Di Nola, M L Soranzo
Panminerva Medica|April 1, 1972
Virus infections and endocrine diseasesF Di Nola, M L Soranzo
Giornale Di Malattie Infettive E Parassitarie|October 1, 1970
[Incidence of encephalitis caused by parotitis]M L Soranzo, G C Paggi
Minerva Medica|March 17, 1973
[On the chemoantibiotic therapy of brucellosis]F Di Nola, M L Soranzo
Minerva Medica|April 14, 1983
[Pneumococcal infections]F Di Nola, M L Soranzo
Pageof 6